Evotec SE (EVO) Earnings Date & Reports

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

EVO is expected to report earnings to fall 125.72% to -1 cents per share on May 06

Q1'25

Est.

$-0.01

Q4'24

Beat

by $0.08

Q3'24

Est.

$-0.12

Q2'24

Missed

by $0.26

Q1'24

Est.

$-0.06

The last earnings report on April 17 showed earnings per share of 4 cents, beating the estimate of -3 cents. With 494.08K shares outstanding, the current market capitalization sits at 2.77B.

View a ticker or compare two or three

Compare

EVO